RECRUITING

VR and Cooled Genicular Nerve Radio Frequency Ablation for Chronic Knee Pain

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study will examine the impact of virtual reality used in conjunction with sedation compared to sedation alone in patients undergoing watervcooled genicular nerve ablations for chronic knee pain. The goals of the study is to determine the relative efficacy of virtual reality as a distraction modality when used as an adjuvant to procedural sedation compared to sedation alone for procedure related pain. To assess procedural satisfaction, and 1-month pain and functional outcomes.To explore whether virtual reality and lower procedure-related pain scores affect 1-month outcomes. And finally to determine whether demographic and clinical characteristics are associated with outcome measures.

Official Title

Can Virtual Reality Improve Patient Tolerance in Patients Undergoing Water Cooled Genicular Nerve Radio Frequency Ablation in Patients With Chronic Knee Pain? A Randomized Controlled Trial

Quick Facts

Study Start:2024-01-12
Study Completion:2027-02-28
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06336447

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Patients undergoing genicular RFA will be eligible for inclusion in the study
  2. * Patients with knee pain, baseline average of \> 4/10
  3. * X-ray evidence of osteoarthritis of the knee
  4. * Pain duration of \>6 weeks and no previous knee surgeries
  5. * Patients will also only be included who have never undergone a RFA on the affected knee
  1. * Individuals who do not have evidence of osteoarthritis on X-ray,
  2. * Secondary gain expected to influence treatment outcomes
  3. * Poorly controlled psychiatric condition that could affect outcome (e.g. active substance abuse) or impose a barrier to participation
  4. * Chronic opioid use and anticoagulation therapy that cannot be stopped and could warrant a different treatment approach (e.g. phenol ablation)
  5. * Severe motion sickness
  6. * Seizure disorder
  7. * Vision loss
  8. * Pregnant
  9. * Nursing

Contacts and Locations

Study Contact

Paul Fitzgerald, RN,BSN,MS
CONTACT
312-695-1064
p-fitzgerald2@northwestern.edu

Principal Investigator

Jason Ross, MD
PRINCIPAL_INVESTIGATOR
Northwestern Univesity

Study Locations (Sites)

Northwestern Medicine Pain Center
Chicago, Illinois, 60611
United States

Collaborators and Investigators

Sponsor: Northwestern University

  • Jason Ross, MD, PRINCIPAL_INVESTIGATOR, Northwestern Univesity

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-01-12
Study Completion Date2027-02-28

Study Record Updates

Study Start Date2024-01-12
Study Completion Date2027-02-28

Terms related to this study

Keywords Provided by Researchers

  • Pain
  • Knee Pain
  • Virtual Reality
  • Radio Frequency Ablation
  • Genicular Nerve Block

Additional Relevant MeSH Terms

  • Pain, Chronic